Page last updated: 2024-09-04

atazanavir sulfate and Hypercholesterolemia

atazanavir sulfate has been researched along with Hypercholesterolemia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sungkanuparph, S; Wangpatharawanit, P	1
Laurence, J	1
Behrens, GM; Castro-Frenzel, B; Christensen, S; Esser, S; Fätkenheuer, G; Lubach-Ruitman, M; Möbius, U; Rump, JA; Schmidt, RE; Stoll, M; Voigt, E	1

Reviews

1 review(s) available for atazanavir sulfate and Hypercholesterolemia

Article	Year
HIV therapeutics, continued: another HIV protease inhibitor approved. The AIDS reader, 2003, Volume: 13, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Drug Approval; Drug Resistance, Viral; Headache; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Hypercholesterolemia; Nausea; Oligopeptides; Patient Selection; Pyridines; Treatment Outcome; United States; United States Food and Drug Administration; Viral Load	2003

Article

Year

HIV therapeutics, continued: another HIV protease inhibitor approved.

The AIDS reader, 2003, Volume: 13, Issue:8

Topics: Acquired Immunodeficiency Syndrome; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Drug Approval; Drug Resistance, Viral; Headache; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Hypercholesterolemia; Nausea; Oligopeptides; Patient Selection; Pyridines; Treatment Outcome; United States; United States Food and Drug Administration; Viral Load

2003

Trials

2 trial(s) available for atazanavir sulfate and Hypercholesterolemia

Article	Year
Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 09-15, Volume: 63, Issue:6 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Atorvastatin; Cholesterol; Female; HIV Infections; Humans; Hypercholesterolemia; Lipoproteins, LDL; Lopinavir; Male; Middle Aged; Ritonavir	2016
Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia. Journal of acquired immune deficiency syndromes (1999), 2005, Jun-01, Volume: 39, Issue:2 Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cholesterol; Cohort Studies; Female; HIV Infections; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Male; Middle Aged; Oligopeptides; Pyridines; Triglycerides	2005

Article

Year

Switching Lopinavir/Ritonavir to Atazanavir/Ritonavir vs Adding Atorvastatin in HIV-Infected Patients Receiving Second-Line Antiretroviral Therapy With Hypercholesterolemia: A Randomized Controlled Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 09-15, Volume: 63, Issue:6

Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Atorvastatin; Cholesterol; Female; HIV Infections; Humans; Hypercholesterolemia; Lipoproteins, LDL; Lopinavir; Male; Middle Aged; Ritonavir

2016

Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia.

Journal of acquired immune deficiency syndromes (1999), 2005, Jun-01, Volume: 39, Issue:2

Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cholesterol; Cohort Studies; Female; HIV Infections; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Male; Middle Aged; Oligopeptides; Pyridines; Triglycerides

2005